Today: 23 March 2026
Browse Category

Stock Market 9 January 2026

Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

Texas Instruments shares rose 1% to $190.24 Friday as chipmakers rallied, with the Philadelphia Semiconductor Index up 2.6% and the S&P 500 hitting a record. U.S. nonfarm payrolls increased by 50,000 in December, while unemployment dipped to 4.4%. Taiwan Semiconductor reported a 20% jump in Q4 revenue, beating forecasts. Texas Instruments will report Q4 earnings on Jan. 27.
Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

Constellation Energy shares climbed 5.6% to $340.51 Friday after TD Cowen began coverage with a buy rating and $440 target. The move followed Constellation’s completed acquisition of Calpine, creating the largest U.S. electricity producer. Meta’s 20-year nuclear power deals lifted sector peers. The DOJ cleared the Calpine deal last month with required divestitures.
Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola shares rose 1.4% to $70.33 Friday, topping $70 as investors favored consumer staples after a weaker-than-expected U.S. jobs report. Nonfarm payrolls increased by 50,000 in December, missing forecasts, while unemployment dipped to 4.4%. The Consumer Staples Select Sector SPDR Fund gained 0.9%. Markets await the December CPI report on Jan. 13 and the Fed’s policy meeting later this month.
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity shares dropped 2.9% to $95.64 Friday after Goldman Sachs downgraded the stock to sell and set an $89 target. The move followed HealthEquity’s raised fiscal 2026 revenue outlook and a report of $34.4 billion in HSA assets. KeyBanc maintained an Overweight rating and lifted its price target to $125. The stock fell as the S&P 500 and Nasdaq 100 rose.
P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

Procter & Gamble agreed to change Kid’s Crest toothpaste packaging and marketing after pressure from Texas Attorney General Ken Paxton, who cited concerns over dosing for children. New labels began rolling out Jan. 1, with P&G required to comply for five years. Shares rose 0.3% to $141.92 Friday. A private lawsuit over Kid’s Crest labels remains active in Chicago.
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio shares fell 4.7% to $8.05 Friday afternoon, underperforming biotech peers. UBS began coverage at Neutral with a $10 target, while RBC raised its target to $9 and reiterated Outperform. CEO David Hung is set to present at the J.P. Morgan Healthcare Conference on Jan. 13. Investors await early March results for updates on IBTROZI’s launch and pipeline spending.
9 January 2026
AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

AST SpaceMobile shares climbed 8.6% to $98.34 Friday after Bank of America raised its price target to $100, maintaining a Neutral rating. The rebound followed a sharp drop earlier in the week. Scotiabank downgraded the stock to Sector Underperform, citing high valuation and lack of retail customers. Investors await the next earnings report, expected March 2, for updates on satellite rollout and customer uptake.
PVH stock slips as Supreme Court tariff decision hangs over retailers — what traders watch next

PVH stock slips as Supreme Court tariff decision hangs over retailers — what traders watch next

PVH Corp shares slid 4.4% to $65.32 Friday afternoon, underperforming the consumer discretionary sector, after the U.S. Supreme Court delayed a decision on Trump-era tariffs until Jan. 14. PVH has warned tariffs could cut 2025 earnings by $65 million. Interim CFO Melissa Stone reported holding 15,410 shares in a recent SEC filing. Investors are watching for any tariff policy changes that could affect costs.
9 January 2026
Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce shares slipped 0.2% to $260.01 after unveiling its Spring ’26 product release, featuring new AI and automation tools, set to roll out from Feb. 23. U.S. payrolls rose by 50,000 in December, below forecasts, while unemployment fell to 4.4%. The S&P 500 hit a record intraday high after the jobs report. Fed funds futures priced in a 4.8% chance of a rate cut at the next Fed meeting.
MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip shares fell 4.5% to $78.78 in Friday afternoon trading, underperforming U.S.-listed travel peers. The stock hit a session high of $83.42 before sliding, with no new company updates ahead of its expected Jan. 22 earnings. Trading volume reached about 577,000 shares by mid-session. The drop puts MakeMyTrip near its lowest levels since early January.
Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

lululemon athletica shares fell 4.9% to $201.88 Friday after the U.S. Supreme Court delayed a key tariffs ruling. The company warned higher tariffs and loss of the “de minimis” exemption could cut 2025 gross profit by $240 million. Investors also weighed an upcoming CEO transition and a proxy fight from founder Chip Wilson. The court could rule next week.
WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 shares dropped 5.6% to $192.13 after reporting a first-quarter profit decline and higher expenses, with the stock hitting a session low near $175. Net sales rose 1% to $154.4 million, but diluted EPS fell to $1.28 from $1.39. Management reaffirmed full-year guidance and blamed weak distributor markets for the profit slip. Investors await more detail at the Jan. 13 ICR Conference.
Atour Lifestyle (ATAT) stock slides about 4% in U.S. trade as rate bets shift, CPI looms

Atour Lifestyle (ATAT) stock slides about 4% in U.S. trade as rate bets shift, CPI looms

Atour Lifestyle Holdings’ U.S. shares dropped 4.2% to $40.20 in early afternoon trading Friday, outpacing losses in other China travel stocks. The move followed weaker-than-expected U.S. payrolls data and uncertainty over Federal Reserve policy and tariffs. Trading volume reached about 894,000 shares. Investors now await the U.S. CPI report on Jan. 13.
Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate Technology rose 5.4% to $299.92 after Goldman Sachs raised its price target to $310, citing strong 2026 pricing forecasts. The gain followed a 7.7% drop the previous day. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring late Thursday. Seagate’s next earnings report is expected around Jan. 20, though the date is unconfirmed.

Stock Market Today

  • TCS Stock Gains on AI Contract Optimism, Closes at INR 2,383.80 on NSE
    March 23, 2026, 8:53 AM EDT. Tata Consultancy Services (TCS.NS) stock closed at INR 2,383.80 on March 23, 2026, up 1.18% with volumes exceeding the average. Investors are focusing on AI-related contracts and guidance ahead of the April earnings call. The stock trades below its 50- and 200-day moving averages amid technology sector weakness but offers a solid trailing PE of 18.14 and strong fundamentals, including a return on equity of 46.26%. TCS's AI platforms, including TwinX and ignio, are driving growth expectations in banking, retail, and life sciences. Technical indicators show the stock as oversold, while AI-driven revenue growth remains a key catalyst. Meyka AI rates TCS a B+ with a 12-month price target of INR 2,800, highlighting a potential 17.46% upside.
Go toTop